Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/34066
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18076/20274 (89%)
Visitors : 5269252      Online Users : 1312
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34066


    Title: Alterations of plasma cytokine biomarkers for identifying age at onset of schizophrenia with neurological soft signs
    Authors: Liu, Jia-Yun
    Chen, Han-Yu
    Lin, Jin-Jia
    Lu, Ming-Kun
    Tan, Hung-Pin
    Jang, Fong-Lin
    Lin, Sheng-Hsiang
    Contributors: Natl Cheng Kung Univ, Coll Med, Inst Clin Med
    Changhua Christian Hosp, Ctr Med Genet, Dept Med Res
    Changhua Christian Hosp, Ctr Med Genet, Dept Genom Med
    Chimei Med Ctr, Dept Psychiat
    Jianan Mental Hosp, Dept Hlth
    Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth
    Kaohsiung Vet Gen Hosp, Dept Psychiat, Tainan Branch
    Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth
    Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth
    Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Biostat Consulting Ctr
    Keywords: schizophrenia
    early-onset
    immune dysregulation
    neurodevelopment
    discriminant analysis
    Date: 2020
    Issue Date: 2022-11-18 11:22:31 (UTC+8)
    Publisher: Ivyspring Int Publ
    Abstract: Several studies have been suggested that immunity plays a part in neurodevelopment and schizophrenia pathogenesis. Early age of onset in schizophrenia is associated with genetic factors which affect neurodevelopment. This study aims to identify immune abnormalities associated with neurodevelopmental impairments in early-onset schizophrenia (EOS) and adult-onset schizophrenia (AOS) patients. We determined the plasma levels of six cytokines (IL-1 beta, IL-4, IL-6, IL-10, IL-12 and TNF-alpha) in schizophrenia patients and healthy controls. Measurements included neurological soft signs (NSS) to distinguish and subgroup those with neurodevelopmental impairments. The study included 210 schizophrenia patients, which were divided into 84 EOS and 126 AOS patients, as well as 122 healthy controls. We observed significant differences in levels of IL-4, IL-6 and IL-10 between EOS and AOS patients. The results demonstrated the area under ROC curve (AUC) of the IL-4 in EOS and healthy controls was 0.81. Moreover, these results indicated that AUC of the IL-4 and the combination of IL-4, IL-6 and IL-12 in EOS with NSS and healthy controls were 0.91 and 0.95. These cytokines are altered in EOS and schizophrenia patients with neurodevelopmental impairments and demonstrated good classification abilities. These findings manifested that both pro- and anti-inflammatory cytokines are contributed to the clinical and pathophysiological features of schizophrenia. Future works are expected to explore potential genetic effectors and predictors as well as therapeutic directions in personalized medicine for early-onset schizophrenia.
    Relation: International Journal of Medical Sciences, v.17, n.2, pp.8
    Appears in Collections:[Dept. of Life and Health Science] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    10.7150_ijms.38891.pdf403KbAdobe PDF177View/Open
    index.html0KbHTML612View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback